Optimization of the Genome Editing CRISPR-Cas9 Technology in Scedosporium apiospermum

Kévin Ravenel1, Wilfried Poirier1, Bienvenue Razafimandimby1

  • 1IRF (Infections Respiratoires Fongiques), Univ Angers, Univ Brest, SFR ICAT 4208, Angers, France.

Mycopathologia
|September 29, 2025
PubMed

Insights

CRISPR-Cas9 technology was optimized for Scedosporium species, enabling efficient gene disruption. This advancement facilitates functional genomic studies in these opportunistic fungal pathogens.

Area of Science:

  • Mycology
  • Molecular Biology
  • Genetic Engineering

Background:

  • Scedosporium species are opportunistic fungal pathogens causing diverse human infections.
  • Limited genetic tools hinder understanding of Scedosporium pathogenic mechanisms.
  • Functional genomic studies in Scedosporium are complicated by high non-homologous end joining rates.

Purpose of the Study:

  • To optimize CRISPR-Cas9 technology for gene editing in Scedosporium species.
  • To develop efficient methods for gene disruption in both wild-type and mutant Scedosporium strains.
  • To facilitate future functional genomic and complementation studies in Scedosporium.

Main Methods:

  • Utilized in vitro assembled Cas9 ribonucleoprotein (RNP) complexes for CRISPR-Cas9 gene editing.
  • Developed a dual RNA-guided Cas9 system for targeted gene cleavage and disruption via homologous recombination in a KU70 deletion mutant.
  • Employed two Cas9 RNP complexes for efficient gene deletion in the wild-type strain without prior KU70 disruption.

Main Results:

  • Successfully disrupted four dioxygenase genes in the ΔKU70 Scedosporium mutant using the dual Cas9 RNP approach with a hygromycin resistance cassette.
  • Achieved efficient deletion of a dioxygenase gene in the wild-type strain using only two Cas9 RNP complexes, with up to 20% efficiency.
  • Demonstrated that the optimized CRISPR-Cas9 methods overcome limitations associated with non-homologous recombination and limited selection markers.

Conclusions:

  • Optimized CRISPR-Cas9 RNP technology provides a powerful and efficient tool for genetic manipulation in Scedosporium species.
  • The developed methods enable targeted gene disruption, paving the way for advanced functional genomic analyses.
  • These advancements are crucial for understanding the pathogenicity of Scedosporium and developing targeted interventions.